Literature DB >> 25932265

Multicentric Castleman's disease with renal amyloidosis and mesangial proliferative glomerulonephritis: a case report.

Zhicheng Tan1, Lihua Wang1, Chen Wang2, Lifang Gao2, Yanrong Yang1.   

Abstract

Renal involvement is a significant complication of multicentric Castleman's disease (MCD) and various glomerular involvements have been reported. A 56-year-old Chinese woman presented with proteinuria and skin rash, with lymphadenopathy and hypergammaglobulinemia. Lymph nodes and skin biopsy proven the case was multicentric CD with plasma cell pathological pattern. The renal biopsy was performed and six glomeruli were observed and two of these showed global sclerosis. Moderate increasing of mesangial matrix with mesangial cell proliferation were seen in every glomerulus. In addition, one-segmental sclerosis accompanied by adhesion of the Bowman's capsule was revealed. Two of the glomeruli had crescents formation. Under immunofluorescence microscopy, immunofluorescence for anti-IgA, IgM, C3, C1q and FRA showed coarse and fine granular depositions along capillary walls and sparsely in the mesangium. Staining for anti-IgG was negative. Under electron microscopy revealed indiscriminate amyloidal deposits in glomerular basement membrane. The foot process of glomerular podocytes was fusion. Moderate increasing of mesangial matrix and mesangial cell proliferation were found. Subsequently, she was successfully treated with prednisone combined with cyclophosphamide therapy not only for proteinuria but also for renal function.

Entities:  

Keywords:  Hypergammaglobulinemia; amyloidosis; lymph node hyperplasia; mesangial proliferative glomerulonephritis; multicentric Castleman’s disease

Year:  2015        PMID: 25932265      PMCID: PMC4402912     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

Review 2.  The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.

Authors:  Corey Casper
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

Review 3.  Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.

Authors:  Xiang-Gui Yuan; Wen Hu; Fei-Fei Chen; Bin-Feng Huang; Xiao-Ying Zhao
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

4.  Treatment of unicentric Castleman disease with neoadjuvant rituximab.

Authors:  Bradley Bandera; Craig Ainsworth; James Shikle; Erik Rupard; Michael Roach
Journal:  Chest       Date:  2010-11       Impact factor: 9.410

5.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

6.  Castleman's disease: more questions than answers.

Authors:  G Frizzera
Journal:  Hum Pathol       Date:  1985-03       Impact factor: 3.466

7.  Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.

Authors:  G M Chronowski; C S Ha; R B Wilder; F Cabanillas; J Manning; J D Cox
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

8.  A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion.

Authors:  Kei Nagai; Joichi Usui; Kazuyuki Noguchi; Kei Unai; Akira Hiwatashi; Yoh Arakawa; Amane Togashi; Naoki Morito; Chie Saito; Keigyou Yoh; Syuichi Tsuruoka; Hiroshi Kojima; Kumi Aita; Michio Nagata; Kunihiro Yamagata
Journal:  Pathol Int       Date:  2011-10-21       Impact factor: 2.534

9.  Atypical Lymphoproliferative Diseases.

Authors:  Timothy Greiner; James O. Armitage; Thomas G. Gross
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2000

Review 10.  Treatment of Castleman's disease.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2005-05
View more
  1 in total

Review 1.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.